Eritel CH 6.25 Tablet
Marketer
Eris Lifesciences Ltd
Salt Composition
Telmisartan (40mg) + Chlorthalidone (6.25mg)
Overview Eritel CH 6.25 Tablet
Eritel CH 6.25 tablets combine two medications to effectively manage hypertension. This reduces your future risk of stroke and heart attack. Eritel CH 6.25 can be taken with or without food; dosage is personalized based on your response and health. Consistent daily timing is recommended, and continuous use, as directed by your physician, is crucial. The formulation includes a diuretic, increasing urination, so avoid taking it within four hours of bedtime. Regular use, even feeling well, maximizes benefits. Hypertension often lacks symptoms, and discontinuation increases stroke/heart attack risk. Common side effects include dizziness; others, less frequent, are nausea, diarrhea, headache, and altered cholesterol levels. Increased urination is expected, a key component of blood pressure control. While rare, other side effects may occur. Review the patient information leaflet; report persistent or bothersome side effects to your doctor for potential dose adjustment or alternative medication. This medication is unsuitable during pregnancy and requires doctor consultation if you have kidney, liver, heart, or diabetic conditions. Alcohol consumption may enhance blood pressure reduction, potentially worsening side effects.
Primary Ingredients of Eritel CH 6.25 Tablet
There is no text provided to rephrase.
Uses of Eritel CH 6.25 Tablet
Elevated blood pressure
Major Benefits of Eritel CH 6.25 Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Eritel CH 6.25 Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Eritel CH 6.25 Tablet:
- Dizziness
- Back pain
- Sinus infection
- Diarrhea
- Red spots or bumps
- Decreased potassium level in blood
- Increased uric acid level in blood
- Postural hypertension (high blood pressure)
- Impotence
- Loss of appetite
- Gastrointestinal disturbance
How to use Eritel CH 6.25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Eritel CH 6.25 Tablets can be administered with or without food, though consistent timing is recommended.
How Eritel CH 6.25 Tablet works:
Each Eritel CH 6.25 Tablet contains a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Eritel CH 6.25 Tablet and alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Using Eritel CH 6.25 Tablet during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Eritel CH 6.25 Tablet are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Taking Eritel CH 6.25 Tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Eritel CH 6.25 Tablet, potentially requiring dosage modification. A physician's consultation is advised; this medication is generally unsuitable for such individuals.
LiverCAUTION
Patients with liver impairment should use Eritel CH 6.25 Tablet cautiously, potentially requiring a modified dosage. Physician consultation is advised. Eritel CH 6.25 Tablet is contraindicated for individuals with severe hepatic dysfunction.
What if you forget to take Eritel CH 6.25 Tablet :
Should you forget to take a dose of Eritel CH 6.25 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Eritel CH 6.25 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |




